ID LYN_RAT STANDARD; PRT; 511 AA. AC Q07014; Q63320; DT 01-JUN-1994 (Rel. 29, Created) DT 01-NOV-1997 (Rel. 35, Last sequence update) DT 30-MAY-2000 (Rel. 39, Last annotation update) DE TYROSINE-PROTEIN KINASE LYN (EC 2.7.1.112). GN LYN. OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Rodentia; Sciurognathi; Muridae; Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP SEQUENCE FROM N.A. RA Minoguchi K., Nishikata H., Siraganian R.P.; RT "Bacterially expressed rat p56lyn binds several proteins in rat RT basophilic leukemia cells including pp72, a tyrosine phosphorylated RT protein prominent in activated cells."; RL J. Immunol. 150:222-222(1993). RN [2] RP SEQUENCE FROM N.A. RX MEDLINE=94171041; PubMed=8125304; RA Rider L.G., Raben N., Miller L., Jelsema C.; RT "The cDNAs encoding two forms of the LYN protein tyrosine kinase are RT expressed in rat mast cells and human myeloid cells."; RL Gene 138:219-222(1994). RN [3] RP SEQUENCE FROM N.A. RX MEDLINE=97442484; PubMed=9295361; RA Vonakis B.M., Chen H., Haleem-Smith H., Metzger H.; RT "The unique domain as the site on Lyn kinase for its constitutive RT association with the high affinity receptor for IgE."; RL J. Biol. Chem. 272:24072-24080(1997). CC -!- CATALYTIC ACTIVITY: ATP + A PROTEIN TYROSINE = ADP + CC PROTEIN TYROSINE PHOSPHATE. CC -!- ALTERNATIVE PRODUCTS: 2 ISOFORMS; LYN A (SHOWN HERE) AND LYN B; CC ARE PRODUCED BY ALTERNATIVE SPLICING. CC -!- TISSUE SPECIFICITY: EXPRESSED PREDOMINANTLY IN B-LYMPHOID AND CC MYELOID CELLS. CC -!- SIMILARITY: CONTAINS 1 SH2 DOMAIN. CC -!- SIMILARITY: CONTAINS 1 SH3 DOMAIN. CC -!- SIMILARITY: TO OTHER PROTEIN-TYROSINE KINASES IN THE CATALYTIC CC DOMAIN. BELONGS TO THE SRC SUBFAMILY. CC -------------------------------------------------------------------------- CC This SWISS-PROT entry is copyright. It is produced through a collaboration CC between the Swiss Institute of Bioinformatics and the EMBL outstation - CC the European Bioinformatics Institute. There are no restrictions on its CC use by non-profit institutions as long as its content is in no way CC modified and this statement is not removed. Usage by and for commercial CC entities requires a license agreement (See http://www.isb-sib.ch/announce/ CC or send an email to license@isb-sib.ch). CC -------------------------------------------------------------------------- DR EMBL; L14951; AAA41549.1; -. DR EMBL; L14782; AAA20944.1; -. DR EMBL; L14823; AAA20945.1; -. DR EMBL; AF000300; AAB71344.1; -. DR EMBL; AF000301; AAB71345.1; -. DR EMBL; AF000302; AAB71346.1; -. DR HSSP; P08631; 2HCK. DR INTERPRO; IPR000719; -. DR INTERPRO; IPR000980; -. DR INTERPRO; IPR001245; -. DR INTERPRO; IPR001452; -. DR PFAM; PF00017; SH2; 1. DR PFAM; PF00018; SH3; 1. DR PFAM; PF00069; pkinase; 1. DR PRINTS; PR00109; TYRKINASE. DR PRINTS; PR00452; SH3DOMAIN. DR PROSITE; PS00107; PROTEIN_KINASE_ATP; 1. DR PROSITE; PS00109; PROTEIN_KINASE_TYR; 1. DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1. DR PROSITE; PS50001; SH2; 1. DR PROSITE; PS50002; SH3; 1. KW Proto-oncogene; Tyrosine-protein kinase; Phosphorylation; KW Transferase; ATP-binding; Myristate; SH2 domain; SH3 domain; KW Palmitate; Lipoprotein; Alternative splicing. FT INIT_MET 0 0 BY SIMILARITY. FT LIPID 1 1 MYRISTATE (BY SIMILARITY). FT LIPID 2 2 PALMITATE (BY SIMILARITY). FT DOMAIN 62 122 SH3. FT DOMAIN 128 225 SH2. FT DOMAIN 246 500 PROTEIN KINASE. FT NP_BIND 252 260 ATP (BY SIMILARITY). FT BINDING 274 274 ATP (BY SIMILARITY). FT ACT_SITE 366 366 BY SIMILARITY. FT MOD_RES 396 396 PHOSPHORYLATION (AUTO-) (BY SIMILARITY). FT MOD_RES 507 507 PHOSPHORYLATION (BY SIMILARITY). FT VARSPLIC 24 44 MISSING (IN ISOFORM LYN B). FT CONFLICT 230 230 P -> L (IN REF. 2). FT CONFLICT 307 307 V -> A (IN REF. 2). FT CONFLICT 418 418 C -> Y (IN REF. 2). SQ SEQUENCE 511 AA; 58529 MW; 24A2E5E229CD43ED CRC64; GCIKSKRKDN LNDDGVDMKT QPVRNTDRTI YVRDPTSNKQ QRPVPESQLL PGQRFQAKDP EEQGDIVVAL YPYDGIHPDD LSFKKGEKMK VLEEHGEWWK AKSLSSKREG FIPSNYVAKV NTLETEEWFF KDITRKDAER QLLAPGNSAG AFLIRESETL KGSFSLSVRD YDPMHGDVIK HYKIRSLDNG GYYISPRITF PCISDMIKHY QKQSDGLCRR LEKACISPKP QKPWDKDAWE IPRESIKLVK KLGAGQFGEV WMGYYNNSTK VAVKTLKPGT MSAQAFLEEA NLMKTLQHDK LVRLYAVVTK EEPIYIITEF MAKGSLLDFL KSDEGSKVLL PKLIDFSAQI AEGMAYIERK NYIHRDLRAA NVLVSESLMC KIADFGLARV IEDNEYTARE GAKFPIKWTA PEAINFGCFT IKSDVWSFGI LLYEIVTYGK IPYPGRTNAD VMTALSQGYR MPRMENCPDE LYDIMKMCWK ESAEERPTFD YLQSVLDDFY TATEGQYQQQ P //